We are live on ! Find out more
ZEAL

Zealand Pharma A/S American Depositary Shares

Delisted

ZEAL was delisted on the 29th of September, 2022.

11 hedge funds and large institutions have $10.4M invested in Zealand Pharma A/S American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

10% more funds holding

Funds holding: 1011 (+1)

17% less capital invested

Capital invested by funds: $12.5M → $10.4M (-$2.1M)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$6.52M +$6.43M +500,916 New
Bank of America
2
Bank of America
North Carolina
$2.87M -$10.9K -846 -0.4%
AIC
3
AWM Investment Company
New York
$631K -$73.7K -5,743 -10%
Jane Street
4
Jane Street
New York
$312K +$3.36K +262 +1%
Morgan Stanley
5
Morgan Stanley
New York
$87K +$2.56K +200 +3%
US Bancorp
6
US Bancorp
Minnesota
$7K
BlackRock
7
BlackRock
New York
$6K
UBS Group
8
UBS Group
Switzerland
$4K -$7K -546 -61%
CS
9
Credit Suisse
Switzerland
$4K +$3.66K +285 New
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$1K
Wells Fargo
11
Wells Fargo
California
$1K
FCM
12
Farallon Capital Management
California
-$7.75M -496,890 Closed